Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial

Litong Qi1 Peking University First Hospital, Beijing, 100034, People’s Republic of China

Qiuling Zhang2 The Affiliated Hospital of Hangzhou Normal University, Hangzhou City, Zhejiang, 310015, People’s Republic of China

Zeqi Zheng3 The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi, 330000, People’s Republic of China

Zhaohui Pei4 The Third Hospital of Nanchang, Nanchang City, Jiangxi, 330000, People’s Republic of China

Hong Mao5 The Central Hospital of Wuhan, Wuhan City, Hubei, 430014, People’s Republic of China

Tingbo Jiang6 The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu, 215006, People’s Republic of China

Dmitri Kazei7 Abbott Healthcare Products BV, Weesp, 1381 CT, The Netherlands

Elke Kahler8 Abbott Laboratories GmbH, Hannover, 30173, Germany

Yong Huo1 Peking University First Hospital, Beijing, 100034, People’s Republic of ChinaCorrespondence[email protected]

Your download is now in progress and you may close this window